Axon Capital’s ASML ASML Stock Holding History

Axon Capital’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.44M	Buy	2,230 +430	+24%	+$684K	6.02%	8
2026 Q1	$2.38M	Buy	+1,800	New	+$2.47M	3.43%	12

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Axon Capital's ASML Position: Q2 2026 in Review

Axon Capital increased its ASML (ASML) stake by 24% in Q2 2026, buying an estimated $684K and bringing the position to 2,230 shares worth $4.44M. The position accounts for 6.02% of the portfolio, ranked #8.

Axon Capital first reported a position in ASML in Q1 2026 and has held it in 2 quarters since. 2,503 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Axon Capital held 2,230 shares of ASML worth $4.44M as of Q2 2026.
Axon Capital bought 430 ASML shares in Q2 2026, an estimated $684K.
ASML made up 6.02% of Axon Capital's portfolio in Q2 2026, its #8 holding.
Axon Capital first reported a position in ASML in Q1 2026 and has held it in 2 quarters since.
2,503 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Axon Capital's 13F filing for Q2 2026, filed 4 Aug 2026.